BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

EKR Therapeutics, Inc. 

7 East Frederick Place

Cedar Knolls  New Jersey  07927  U.S.A.
Phone: 877-435-2524 Fax: 866-254-1491


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





 Company News
Cornerstone Therapeutics Inc. Completes Acquisition of EKR Therapeutics, Inc. 6/27/2012 9:04:40 AM    More...
Cornerstone Therapeutics Inc. Reports First Quarter 2012 Financial Results 5/15/2012 9:03:52 AM    More...
Cornerstone Therapeutics Inc. to Acquire EKR Therapeutics, Inc. for $125 Million Cash, Plus $25 Million in Milestones 5/15/2012 6:47:57 AM    More...
EKR Therapeutics, Inc. Names Two Independent Directors and Reaffirms Board of Directors to Lead Company Growth in the Critical Care Sector 12/15/2011 9:45:16 AM    More...
EKR Therapeutics, Inc. Announces Robert P. Roche Jr. Joins Board of Directors 10/24/2011 10:07:47 AM    More...
EKR Therapeutics, Inc. Announces Senior Management Change 10/14/2011 9:28:36 AM    More...
Rolf A. Classon Joins Board of EKR Therapeutics, Inc. 5/13/2011 10:16:21 AM    More...
EKR Therapeutics, Inc. Release: New Study Demonstrates Ready-to Use Cardene(R) I.V. More Effective than Labetalol for Immediate Control of Blood Pressure in Emergency Room Patients 9/29/2010 8:08:10 AM    More...
EKR Therapeutics, Inc. Names John E. Bailye New Chief Executive Officer 7/22/2010 10:31:39 AM    More...
EKR Therapeutics, Inc. Appoints John Bailye as Interim President & Chief Executive Officer 3/4/2010 6:57:06 AM    More...
1234

//-->